Jan 26, 2024 7:30 am EST BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala
Jan 17, 2024 7:00 am EST BullFrog AI’s Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data
Jan 16, 2024 8:00 am EST BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer
Dec 06, 2023 7:00 am EST BullFrog AI Launches Preclinical Study to Investigate BF-114’s Potential in Battling Obesity
Oct 05, 2023 8:00 am EDT BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform
Sep 26, 2023 8:00 am EDT BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma